James J Vaughn Insider Trading $GHDX GENOMIC HEALTH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James J Vaughn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James J Vaughn. James J Vaughn is Chief Commercial Officer in GENOMIC HEALTH INC ($GHDX).
James J Vaughn in GENOMIC HEALTH INC
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of James J Vaughn: Chief Commercial Officer
Holdings: 11,281 shares
Current Value: $310,115
Latest Transaction: Nov 14 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James J Vaughn in GENOMIC HEALTH INC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 46.83 | 12,448 | 582,891 | 29,655 | 42.1 K to 29.7 K (-29.57 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 46.07 | 7,552 | 347,884 | 42,103 | 49.7 K to 42.1 K (-15.21 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.00 | 20,000 | 540,000 | 49,655 | 29.7 K to 49.7 K (+67.44 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 45.47 | 2,523 | 114,718 | 29,655 | 32.2 K to 29.7 K (-7.84 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 44.67 | 10,977 | 490,333 | 32,178 | 43.2 K to 32.2 K (-25.44 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 27.48 | 13,500 | 370,980 | 43,155 | 29.7 K to 43.2 K (+45.52 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 43.87 | 9,000 | 394,837 | 29,655 | 38.7 K to 29.7 K (-23.28 %) |
| Jun 06 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 22.98 | 9,000 | 206,820 | 38,655 | 29.7 K to 38.7 K (+30.35 %) |
| May 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.50 | 1,497 | 48,653 | 29,655 | 31.2 K to 29.7 K (-4.81 %) |
| Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 33.21 | 46,810 | 1,554,560 | 46,810 | |
| Feb 02 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 6,790 | 0 | 34,267 | 27.5 K to 34.3 K (+24.71 %) |
| Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 2,169 | 37,589 | 0 | |
| Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 34.09 | 835 | 28,465 | 27,477 | 28.3 K to 27.5 K (-2.95 %) |
| Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 34.09 | 2,169 | 73,941 | 28,312 | 30.5 K to 28.3 K (-7.12 %) |
| Jan 04 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 2,169 | 37,589 | 30,481 | 28.3 K to 30.5 K (+7.66 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 100 | 1,733 | 2,169 | |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 824 | 14,280 | 2,269 | |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 1,497 | 25,943 | 3,093 | |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 17.33 | 2,410 | 41,765 | 4,590 | |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.51 | 455 | 14,791 | 27,620 | 28.1 K to 27.6 K (-1.62 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.50 | 100 | 3,250 | 28,075 | 28.2 K to 28.1 K (-0.35 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.51 | 824 | 26,787 | 28,175 | 29 K to 28.2 K (-2.84 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 100 | 1,733 | 28,999 | 28.9 K to 29 K (+0.35 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 824 | 14,280 | 28,899 | 28.1 K to 28.9 K (+2.93 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.59 | 1,710 | 55,737 | 28,075 | 29.8 K to 28.1 K (-5.74 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.58 | 1,497 | 48,765 | 29,785 | 31.3 K to 29.8 K (-4.79 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 32.57 | 2,410 | 78,499 | 31,282 | 33.7 K to 31.3 K (-7.15 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 1,497 | 25,943 | 33,692 | 32.2 K to 33.7 K (+4.65 %) |
| Nov 08 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 17.33 | 2,410 | 41,765 | 32,195 | 29.8 K to 32.2 K (+8.09 %) |
| Aug 09 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 23.31 | 6,500 | 151,515 | 0 | |
| Aug 09 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 30.59 | 8,000 | 244,724 | 29,785 | 37.8 K to 29.8 K (-21.17 %) |
| Aug 09 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 23.31 | 6,500 | 151,515 | 37,785 | 31.3 K to 37.8 K (+20.78 %) |
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Payment of Exercise | F | 31.12 | 3,417 | 106,337 | 30,502 | 33.9 K to 30.5 K (-10.07 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 27.48 | 54,080 | 1,486,118 | 54,080 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 7,840 | 0 | 33,919 | 26.1 K to 33.9 K (+30.06 %) |
| Oct 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 29.68 | 3,000 | 89,042 | 26,079 | 29.1 K to 26.1 K (-10.32 %) |
| Aug 10 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.74 | 3,000 | 86,222 | 29,079 | 32.1 K to 29.1 K (-9.35 %) |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 1,997 | 37,723 | 0 | |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.00 | 1,997 | 55,916 | 32,079 | 34.1 K to 32.1 K (-5.86 %) |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 1,997 | 37,723 | 34,076 | 32.1 K to 34.1 K (+6.23 %) |
| May 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 2,000 | 37,780 | 1,997 | |
| May 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.00 | 2,000 | 56,000 | 31,255 | 33.3 K to 31.3 K (-6.01 %) |
| May 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 2,000 | 37,780 | 33,255 | 31.3 K to 33.3 K (+6.40 %) |
| Feb 17 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 27.00 | 61,700 | 1,665,900 | 61,700 | |
| Feb 17 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 10,550 | 0 | 31,255 | 20.7 K to 31.3 K (+50.95 %) |
| Feb 17 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Payment of Exercise | F | 26.53 | 3,371 | 89,433 | 20,705 | 24.1 K to 20.7 K (-14.00 %) |
| Feb 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 3 | 57 | 3,997 | |
| Feb 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.00 | 3 | 84 | 24,076 | 24.1 K to 24.1 K (-0.01 %) |
| Feb 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 3 | 57 | 24,079 | 24.1 K to 24.1 K (+0.01 %) |
| Jan 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 2,000 | 37,780 | 4,000 | |
| Jan 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 33.63 | 2,000 | 67,265 | 24,076 | 26.1 K to 24.1 K (-7.67 %) |
| Jan 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 2,000 | 37,780 | 26,076 | 24.1 K to 26.1 K (+8.31 %) |
| Dec 09 2015 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 2,000 | 37,780 | 6,000 | |
| Dec 09 2015 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 29.33 | 2,000 | 58,668 | 24,076 | 26.1 K to 24.1 K (-7.67 %) |
| Dec 09 2015 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 2,000 | 37,780 | 26,076 | 24.1 K to 26.1 K (+8.31 %) |